Trial intelligence / Profile preview

Switching from Efavirenz to Maraviroc in HIV-1

NCT01190293Phase 4Completed

Sponsor
St Stephen's AIDS Trust
Start
Jan 2010
Primary completion
Mar 2012
Countries
1
01

Overview

A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Jan 2010; status: completed.

02

Drugs

maraviroc
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01190293.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01190293.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call